Treatment with BsNb PX4 combined with IL-2 considerably enhanced the cytotoxicity of hPBMCs against pancreatic cancer cell lines compared with the effect of IL-2 alone. The gene discussed is IL2; the disease is familial pancreatic carcinoma.